|
Name |
3,4-Dimethylphenyl 3,5-di-tert-butylbenzoate
|
Molecular Formula | C23H30O2 | |
IUPAC Name* |
(3,4-dimethylphenyl) 3,5-ditert-butylbenzoate
|
|
SMILES |
CC1=C(C=C(C=C1)OC(=O)C2=CC(=CC(=C2)C(C)(C)C)C(C)(C)C)C
|
|
InChI |
InChI=1S/C23H30O2/c1-15-9-10-20(11-16(15)2)25-21(24)17-12-18(22(3,4)5)14-19(13-17)23(6,7)8/h9-14H,1-8H3
|
|
InChIKey |
BAILKEIRZMRLMJ-UHFFFAOYSA-N
|
|
Synonyms |
3,4-dimethylphenyl 3,5-di-tert-butylbenzoate; CBDivE_001461; ZINC1853229; 3,4-xylyl 3,5-di-t-butylbenzoate; STK388180; AKOS001572690; 3,4-Xylyl 3,5-di-tert-butylbenzoate; 3,4-Dimethylphenyl 3,5-ditert-butylbenzoate #; SR-01000393852; SR-01000393852-1
|
|
CAS | NA | |
PubChem CID | 612366 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 338.5 | ALogp: | 7.4 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 2 |
Heavy Atoms: | 25 | QED Weighted: | 0.485 |
Caco-2 Permeability: | -6.063 | MDCK Permeability: | 0.00000592 |
Pgp-inhibitor: | 0.904 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.781 | 20% Bioavailability (F20%): | 0.997 |
30% Bioavailability (F30%): | 0.998 |
Blood-Brain-Barrier Penetration (BBB): | 0.03 | Plasma Protein Binding (PPB): | 101.21% |
Volume Distribution (VD): | 0.81 | Fu: | 2.78% |
CYP1A2-inhibitor: | 0.321 | CYP1A2-substrate: | 0.904 |
CYP2C19-inhibitor: | 0.759 | CYP2C19-substrate: | 0.258 |
CYP2C9-inhibitor: | 0.531 | CYP2C9-substrate: | 0.865 |
CYP2D6-inhibitor: | 0.463 | CYP2D6-substrate: | 0.73 |
CYP3A4-inhibitor: | 0.324 | CYP3A4-substrate: | 0.524 |
Clearance (CL): | 5.076 | Half-life (T1/2): | 0.099 |
hERG Blockers: | 0.04 | Human Hepatotoxicity (H-HT): | 0.017 |
Drug-inuced Liver Injury (DILI): | 0.254 | AMES Toxicity: | 0.003 |
Rat Oral Acute Toxicity: | 0.034 | Maximum Recommended Daily Dose: | 0.889 |
Skin Sensitization: | 0.494 | Carcinogencity: | 0.025 |
Eye Corrosion: | 0.067 | Eye Irritation: | 0.971 |
Respiratory Toxicity: | 0.161 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000695 | 0.444 | D0W7WC | 0.321 | ||||
ENC000898 | 0.417 | D0Y4DY | 0.292 | ||||
ENC000185 | 0.351 | D00NJL | 0.287 | ||||
ENC005113 | 0.351 | D01JFT | 0.284 | ||||
ENC000744 | 0.351 | D06RUL | 0.270 | ||||
ENC000294 | 0.351 | D05VIX | 0.267 | ||||
ENC000346 | 0.342 | D06YPU | 0.265 | ||||
ENC001382 | 0.341 | D0H2DQ | 0.260 | ||||
ENC001398 | 0.337 | D07XHO | 0.252 | ||||
ENC000610 | 0.325 | D0H5MB | 0.250 |